Document:

Form of 4.875% Senior Note due 2020

 Exhibit 4.3 
 BIO-RAD LABORATORIES, INC. 
 THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE
FIRST SUPPLEMENTAL INDENTURE GOVERNING THIS NOTE) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (I) THE TRUSTEE MAY MAKE SUCH NOTATIONS
HEREON AS MAY BE REQUIRED PURSUANT TO SECTION 3.02 OF THE FIRST SUPPLEMENTAL INDENTURE, (II) THIS GLOBAL NOTE MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 3.02(a) OF THE FIRST SUPPLEMENTAL INDENTURE, (III) THIS GLOBAL NOTE MAY BE
DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 2.12 OF THE BASE INDENTURE AND (IV) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF THE COMPANY. 

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY
TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS
CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER STREET, NEW YORK, NEW YORK) (“DTC”) TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE
ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR SUCH OTHER ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

  

			
	REGISTERED	 	REGISTERED

 BIO-RAD
LABORATORIES, INC. 
 4.875% Senior Notes due 2020 

 

			
	CUSIP NO. 090572 AP3	 	
	ISIN NO. US090572AP34	 	
	No. R-1	 	US$425,000,000

 Bio-Rad
Laboratories, Inc., a corporation duly organized and existing under the laws of the State of Delaware (herein called the “Company”, which term includes any successor Person under the Indenture hereinafter referred to), for value received,
hereby promises to pay to CEDE & CO., or its registered assigns, the principal sum of Four Hundred Twenty-Five Million Dollars ($425,000,000) on December 15, 2020, and to pay interest thereon from December 9, 2010 or from the most
recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually on June 15 and December 15 in each year, commencing June 15, 2011, to the Persons in whose names the Notes are registered at the close of
business on the immediately preceding June 1 or December 1, as the case may be, at the rate of 4.875% per annum, until the principal hereof is paid or made available for payment, provided, however that any principal and
premium, and any such installment of interest, which is overdue shall bear interest at the rate of 4.875% per annum (to the extent that the payment of such interest shall be legally enforceable), from the dates such amounts are due until they
are paid or made available for payment, and such interest shall be payable on demand). The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in
whose name this Note (or one or more predecessor Notes) is registered at the close of business on the regular record date for such interest, which shall be the June 1 or December 1 (whether or not a Business Day), as the case may be, next
preceding such Interest Payment Date. Interest on the Notes will be computed on the basis of a 360-day year of twelve 30-day months. 
 Payment of the principal of (and premium, if any) and any such interest on this Note will be made at the office or agency of the Company maintained for that purpose, in such coin or currency of the United
States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person
entitled thereto as such address shall appear in the Security Register. 
 Reference is hereby made to the further provisions of
this Note set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the Indenture
or be valid or obligatory for any purpose. 

 IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed. 
  

					
	BIO-RAD LABORATORIES, INC.
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	

 CERTIFICATE OF AUTHENTICATION 

This is one of the Notes of the series designated therein referred to in the within-mentioned Indenture. 

Dated: December 9, 2010 
  

			
	Wilmington Trust FSB,
	as Trustee
		
	By:	 	  

		 	Authorized Signatory

 [Reverse of Note] 
 This Note is one of a duly authorized issue of Securities of the Company (herein called the “Notes”), issued and to be issued in one or more series under an Indenture, dated as of
December 9, 2010 (herein called the “Base Indenture”), between the Company and Wilmington Trust FSB, as trustee (herein called the ‘“Trustee”), as supplemented by the First Supplemental Indenture, dated as of
December 9, 2010 (the “First Supplemental Indenture”), by and between the Company and the Trustee. The Base Indenture as supplemented by the First Supplemental Indenture is referred to herein as the “Indenture.” Capitalized
terms used herein and not otherwise defined shall have the meanings given them in the Base Indenture or the First Supplemental Indenture, as applicable. The terms of the Notes include those stated in the Indenture and those made part of the
Indenture by reference to the TIA as in effect on the date the Indenture is qualified. The Notes are subject to all such terms, and Holders are referred to the Indenture and TIA for a statement of such terms. 

The Notes of this series are subject to redemption at any time, upon not less than 30 days’ and not more than 60 days’ notice
by mail, as a whole or from time to time in part, at the election of the Company, on any date prior to their Stated Maturity at a Redemption Price equal to the greater of (i) 100% of the principal amount of such Notes to be redeemed, and
(ii) the sum of the present values of the Remaining Scheduled Payments (as defined below) of the Notes to be redeemed, discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the
Treasury Rate (as defined below) plus 35 basis points, plus, accrued and unpaid interest thereon to the Redemption Date. Notwithstanding the foregoing, installments of interest on the Notes that are due and payable on Interest Payment Dates
falling on or prior to a Redemption Date will be payable on the Interest Payment Date to the registered Holders as of the close of business on the relevant record date according to the Notes and the Indenture. 

“Comparable Treasury Issue” means the United States Treasury security selected by an Independent Investment Banker as having an
actual or interpolated maturity comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of
comparable maturity to the remaining term of such Notes to be redeemed. 
 “Comparable Treasury Price” means, with
respect to any Redemption Date, (a) the arithmetic average of the Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest of the Reference Treasury Dealer Quotations, (b) if fewer than four
Reference Treasury Dealer Quotations are obtained, the arithmetic average of all of those quotations or (c) if only one Reference Treasury Dealer Quotation is obtained, such Reference Treasury Dealer Quotation. 

“Independent Investment Banker” means one of the Reference Treasury Dealers appointed by the Company. 

“Reference Treasury Dealer” means each of Credit Suisse Securities (USA) LLC and Goldman, Sachs & Co., and their
respective successors, or if at any time any of the above is not a primary U.S. Government securities dealer, any other nationally recognized investment 

 
banking firm selected by the Company that is a primary U.S. Government securities dealer, as well as two other nationally recognized investment banking firms selected by the Company that are
primary U.S. Government securities dealers. 
 “Reference Treasury Dealer Quotations” means, with respect to each
Reference Treasury Dealer and any Redemption Date, the arithmetic average, as determined by the Trustee, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing
to the Trustee by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third Business Day preceding such Redemption Date. 
 “Remaining Scheduled Payments” means, with respect to any Note to be redeemed, the remaining scheduled payments of the principal thereof and interest thereon that would be due after the related
Redemption Date for such redemption; provided, however, that, if such Redemption Date is not an Interest Payment Date with respect to such Note, the amount of the next succeeding scheduled interest payment thereon will be reduced by
the amount of interest accrued thereon to such Redemption Date. 
 “Treasury Rate” means, for any Redemption Date, the
rate per annum equal to the semi-annual equivalent yield to Maturity, computed as of the second Business Day immediately preceding that Redemption Date, of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed
as a percentage of its principal amount) equal to the Comparable Treasury Price for such Redemption Date. 
 In the event of
redemption of this Note in part only, a new Note or Notes of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof. 

The Indenture contains provisions for defeasance at any time of the entire indebtedness of this Note or certain restrictive covenants and
Events of Default with respect to this Note, in each case upon compliance with certain conditions set forth in the Indenture. 

If an Event of Default with respect to Notes of this series shall occur and be continuing, the principal of the Notes of this series may
be declared due and payable in the manner and with the effect provided in the Indenture. 
 The Indenture permits, with certain
exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Notes to be affected under the Indenture at any time by the Company and the Trustee with the
consent of the Holders of a majority in principal amount of the Notes at the time outstanding to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes at the time
outstanding, on behalf of the Holders of all Notes, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this
Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or
waiver is made upon this Note. 

 As provided in and subject to the provisions of the Indenture, the Holder of this Note shall
not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a
continuing Event of Default with respect to the Notes, the Holders of not less than 25% in principal amount of the Notes at the time outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of
Default as Trustee and offered the Trustee indemnity or security satisfactory to it, and the Trustee shall not have received from the Holders of a majority in principal amount of Notes of this series at the time outstanding a direction inconsistent
with such request, and shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the enforcement
of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. 

No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Note at the times, place and rate, and in the coin or currency, herein prescribed. 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Note may be registered and this
Note may be exchanged as provided in the Indenture. 
 The Notes of this series are issuable only in registered form without
coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof. 
 No service charge shall be made for
any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

The Notes of this series shall be governed by and construed in accordance with the laws of the State of New York (including without
limitation Section 5-1401 of the New York General Obligations Law or any successor to such statute). The Trustee and the Company agree to submit to the non-exclusive jurisdiction of any United States federal or state court located in the
borough of Manhattan, in the city of New York in any action or proceeding arising out of or relating to the Notes. 
 All terms
used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture. 

 ASSIGNMENT FORM 
 To assign this Note, fill in the form below: 
 I or we assign and transfer this Note to:

  
  
 (Insert assignee’s social security or tax I.D. no.) 
  

 
  

 
  

 
  

 
 (Print or type assignee’s name,
address and zip code) 
 and irrevocably appoint
                                        
 as agent to transfer this Note on the books of the Company. The agent may substitute another to act for him. 
  

 
  

			
	Your Signature:	 	  

		 	(Sign exactly as your name appears on the other side of this Note)

			
		
	Your Name:	 	  

					
			
	Date:	 	  
	 	

			
		
	Signature Guarantee:	 	 *

 

	*	NOTICE: The Signature must be guaranteed by an Institution which is a member of one of the following recognized signature Guarantee Programs: (i) The Notes
Transfer Agent Medallion Program (STAMP); (ii) The New York Stock Exchange Medallion Program (MNSP); (iii) The Stock Exchange Medallion Program (SEMP); or (iv) such other guarantee program acceptable to the Trustee.

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE 

The following exchanges of an interest in this Global Note for an interest in another Global Note or for a Definitive Note, or exchanges of an interest
in another Global Note or a Definitive Note for an interest in this Global Note have been made: 
  

									
	 Date of Exchange
	  	 Amount of decrease in
 Principal Amount of this
 Global Note
	  	 Amount of increase in
 Principal Amount of this
 Global Note
	  	 Principal Amount of this

Global Note following
 such decrease or
increase
	  	 Signature of authorized
 signatory of Trustee or
 Notes CustodianExhibit 10.1

 Exhibit 10.1 
 [Form of Restricted Stock Grant Award for James A. Hyde and Michael B. Moneymaker] 

December 7, 2010 
 [Name] 

[Address] 
 Dear
            : 
 Pursuant to the NTELOS Holdings Corp. 2010 Equity and Cash
Incentive Plan (the “Plan”), the Plan’s administrative committee (the “Committee”) hereby grants              shares of Restricted Stock, par value $.01
(“Award”). This Award is subject to the applicable terms and conditions of the Plan, which are incorporated herein by reference, and in the event of any contradiction, distinction or difference between this letter and the terms of the
Plan, the terms of the Plan will control. All capitalized terms used herein have the meanings set forth herein or in the Plan, as applicable. 

Subject to your continued employment with the Company and its Affiliates, or, if applicable to you following the “Spin-Off” (as defined below),
with the “Wireline Company” (as defined below), except as otherwise described below, your Award will fully vest and become non-forfeitable on the earlier of: 
  

	(A)	 the fourth
(4th) anniversary of the grant date; and

  

	(B)	 the second
(2nd) anniversary of the effective date of the
consummation of the Company’s spin-off of its wireline business (the “Wireline Company”) consistent in all material respects with the proposed spin-off of the wireline business (the “Spin-Off”) approved by the Company’s
Board of Directors on the grant date. 

 Notwithstanding the preceding time-based vesting schedule,
(A)              shares of Restricted Stock subject to your Award will fully vest and become non-forfeitable at the time described above only if the Company’s wireless
business (the “Wireless Company”) achieves the company performance goals for 2011 to be set forth in the 2011 Team Incentive Plan (“TIP”) for the Wireless Company which would permit payout under the 2011 TIP based upon
achievement of all company factors and no reduction for individual performance issues at a payout percentage of at least 100% (B) another              shares of Restricted Stock
subject to your Award will fully vest and become non-forfeitable at the time described above only if the Wireline Company (or, if applicable, the Company’s Wireline business) achieves the company performance goals for 2011 to be set forth in
the 2011 TIP for the Wireline Company (or, if applicable, the Company’s Wireline business) which would permit payout under the 2011 TIP based upon achievement of all company factors and no reduction for individual performance issues at a payout
percentage of at least 100%. If the Wireless Company and/or the Wireline Company (or, if applicable, the Company’s Wireline business) achieve the applicable company performance goals for 2011 set forth in its respective 2011 TIP which would
permit payout under the 2011 TIP based upon achievement of all company factors and no reduction for individual performance issues at a payout percentage of less than 100%, then the percentage of shares of Restricted Stock subject to these additional
performance-based vesting requirements that vest and become non-forfeitable at the time described above shall equal the payout percentage achieved under the applicable 2011 TIP based upon actual achievement of all company factors and no reduction
for individual performance issues (disregarding for this purpose any minimum threshold level of achievement of company factors that would be required for any payout under the respective 2011 TIP). Any remaining shares of Restricted Stock that are
subject to these additional performance-based vesting requirements shall be forfeited at the time of determination of the TIP payout percentages. The foregoing performance-based vesting requirements apply whether or not you actually participate in
the respective 2011 TIP. 

  

 The following enhanced vesting provision shall also apply to your Award shares in the event your employment
with the Company and its Affiliates or with the Wireline Company, as applicable, terminates under the circumstances described below before your Award shares become vested. 

 

	•	 	 In the event the Company or an Affiliate or the Wireline Company, as applicable, terminates your employment involuntarily and without Cause, then your
entire Award will fully vest and become nonforfeitable immediately prior to your Termination Date; provided that this enhanced vesting provision will not apply in the event of the termination of your employment by the Company or an Affiliate and
your becoming employed by the Wireline Company contemporaneously with the Spin-Off. 

  

	•	 	 You will not be entitled to receive this enhanced vesting if your employment terminates on account of your death, disability, retirement, termination
by the Company for Cause or your voluntary resignation for whatever reason. 

 In addition to the shares of Restricted Stock
granted pursuant to this Award, if the Wireless Company achieves the company performance goals for 2011 set forth in its 2011 TIP which would permit payout under the 2011 TIP based upon achievement of all company factors and no reduction for
individual performance issues at a payout percentage in excess of 100%, then you also will be entitled to receive, at the time of determination of the TIP payout percentage, subject to your continued employment with the Company and its Affiliates,
or, if applicable to you following the Spin-Off, with the Wireline Company, that number of additional shares of Restricted Stock equal to the product of (i) the TIP payout percentage, if any, based upon achievement of all company factors and no
reduction for individual performance issues in excess of 100% and (ii)         . Furthermore, if the Wireline Company (or, if applicable, the Company’s Wireline business) achieves the company
performance goals for 2011 set forth in its 2011 TIP which would permit payout under the 2011 TIP based upon achievement of all company factors and no reduction for individual performance issues at a payout percentage in excess of 100%, then you
also will be entitled to receive, at the time of determination of the TIP payout percentage, subject to your continued employment with the Company and its Affiliates, or, if applicable to you following the Spin-Off, with the Wireline Company, that
number of additional shares of Restricted Stock equal to the product of (i) the TIP payout percentage, if any, based upon achievement of all company factors and no reduction for individual performance issues in excess of 100% and
(ii)         . These additional shares of Restricted Stock then shall become fully vested and nonforfeitable upon satisfaction of the time-based and/or enhanced vesting provisions set forth above.
No additional shares of Restricted Stock shall be awarded if the enhanced vesting provisions apply prior to the time of determination of the TIP payout percentages. 
 By accepting this Award, you agree upon grant of your Award to be bound by the following confidentiality and non-solicitation restrictions: 
 Confidentiality 
 You understand and acknowledge that during your employment with the
Company, you have been and will be making use of, acquiring or adding to the Company’s Confidential Information (as defined below). In order to protect the Confidential Information, you will not, during your employment with the Company or at
any time thereafter, in any way utilize any of the Confidential Information except in connection with your employment by the Company. You will not at any time use any Confidential Information for your own benefit or the benefit of any person except
the Company. At the end of your employment with the Company, you will surrender and return to the Company any and all Confidential Information in your possession or control, as well as any other Company property that is in your possession or
control. The term “Confidential Information” shall mean any information that is 

  
 2 

 
confidential and proprietary to the Company, including but not limited to the following general categories: (a) trade secrets; (b) lists and other information about current and
prospective customers; (c) plans or strategies for sales, marketing, business development, or system build-out; (d) sales and account records; (e) prices or pricing strategy or information; (f) current and proposed advertising
and promotional programs; (g) engineering and technical data; (h) the Company’s methods, systems, techniques, procedures, designs, formula, inventions and know-how; (i) personnel information; (j) legal advice and strategies;
and (k) other information of a similar nature not known or made available to the public or the Company’s competitors. “Confidential Information” shall also include any such information that you may prepare or create during your
employment with the Company, as well as such information that has been or may be created or prepared by others. This promise of confidentiality is in addition to any common law or statutory rights of the Company to prevent disclosure of its trade
secrets and/or Confidential Information. 
 Non-Solicitation 
 While you are employed by the Company and for one (1) year after your Termination Date, you will not, directly or indirectly, solicit or encourage any employee of the Company to terminate employment
with the Company; hire, or cause to be hired, for any employment by a Competitor, any person who within the preceding 12 month period has been employed by the Company, or assist any other person, firm, or corporation to do any of the foregoing acts.
Additionally, while you are employed by the Company and for one (1) year after your Termination Date, you will not, directly or indirectly, sell, attempt to sell, provide or attempt to provide, any wireless or wireline telecommunication
services, including but not limited to internet services, to any person or entity who was a customer or an actively sought prospective customer of the Company, at any time during the Executive’s employment with the Company. 

In the event you breach any of foregoing confidentiality or non-solicitation restrictions, in addition to any contractual or common law right the Company
may have against you, you will waive and forfeit any and all rights to any further benefits under this letter or under the Plan and you will repay the Company for any benefit you may have already received under this letter or under the Plan.

 Taxes 
 Under the Internal
Revenue Code (the “Code”), your restricted stock grant is taxed as ordinary income when the shares fully vest. Upon vesting of your stock, you will be required to pay applicable withholding tax on the stock’s value prior to the stock
being transferred to you. You may elect to have the withholding tax deducted from your regular pay; deducted from a bonus check (if applicable); or make payment directly to NTELOS by a personal check. You may be eligible to make a Section 83(b)
election to accelerate recognition of the income from this award. You should seek advice from a qualified tax advisor immediately if you are considering this election. 
 Dividends 
 Prior to the vesting of your restricted stock, you will be eligible to receive
any dividends that are declared on your restricted stock. Any applicable dividend checks will be mailed to your address of record. Dividends that you receive on restricted stock are treated as ordinary income (compensation) and not as dividend
income. NTELOS will include these payments on your W-2 Wage Statement. If they also are reported on a Form 1099-DIV, Dividends and Distributions, you should list them on Schedule B (Form 1040), with a statement that they have been included as wages
on your W-2. Do not include them in the total dividends received. You should consider reviewing page 13 of IRS Publication 525, “Taxable and Non-Taxable Income” for specific instructions on this issue. 

You will not be eligible to receive, as described above, any dividends on any of the additional shares of Restricted Stock that you might be entitled to
receive unless and until the additional shares of Restricted Stock are actually issued to you. 

  
 3 

 Please contact your tax advisor if you have questions on these tax related issues. 

The Company may impose any additional conditions or restrictions on the Award as it deems necessary or advisable to ensure that all rights granted under
the Plan satisfy the requirements of applicable securities laws. The Company shall not be obligated to issue or deliver any shares if such action violates any provision of any law or regulation of any governmental authority or national securities
exchange. 
 The Committee may amend the terms of this Award to the extent it deems appropriate to carry out the terms of the Plan. The
construction and interpretation of any provision of this Award or the Plan shall be final and conclusive when made by the Committee. 
 Nothing
in this letter shall confer on you the right to continue in the service of the Company or its Subsidiaries or interfere in any way with the right of the Company or its Subsidiaries to terminate your service at any time, which rights shall be subject
to the terms and conditions of any applicable employment agreement or other contractual relationship between you and the Company, if such agreement or other relationship exists. 
 Please sign and return a copy of this agreement to Joe Leigh, Vice President—Human Resources, designating your approval of this letter. This acknowledgement must be returned within thirty
(30) days; otherwise, the Award will lapse and become null and void. Your signature will also acknowledge that you have received and reviewed the Plan and that you agree to be bound by the applicable terms of this letter and the Plan.

  

			
	Very truly yours,
	
	NTELOS HOLDINGS CORP.
		
	By:	 	  

	
	ACKNOWLEDGED AND ACCEPTED
	
	  

		
	Dated:	 	  

  
 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}]]